NCT07768319

Brief Summary

Bulimia Nervosa (BN) is a kind of chronic refractory mental disorder with high prevalence and relapse rate, which would cause serious damage to physical and mental health. Dialectical Behavioral Therapy (DBT) is an internationally effective and evidence-based therapy for BN patients. Previous studies have found that DBT group therapy can significantly improve the core symptoms of BN patients. Our research group has conducted DBT group therapy for BN, and found that after 12 weeks of treatment, the frequencies of binge eating and purging behavior of BN patients were significantly reduced. However, with the high cost of ground-based group therapy and low coverage, it is difficult to promote the G-DBT(Group Dialectical Behavioral Therapy) for BN, considering the shortage of mental health resource in China. Besides, videoconferencing-based psychotherapy has gradually emerged in recent years. However, there is still a lack of clinical studies on the videoconferencing-based G-DBT for BN at home and abroad to confirm its efficacy and feasibility. Therefore, this study intends to use a randomized controlled study by randomly allocating BN patients into videoconferencing-based G-DBT group and traditional G-DBT group for 12 weeks. By comparing the changes of core symptoms and psychological characteristics of BN patients before and after treatment, this study aims to illustrate the efficacy and feasibility of videoconferencing-based G-DBT is no less than traditional G-DBT.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2020

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

August 11, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2023

Completed
2.7 years until next milestone

First Posted

Study publicly available on registry

August 17, 2026

Completed
Last Updated

August 25, 2026

Status Verified

August 1, 2026

Enrollment Period

2 years

First QC Date

August 11, 2022

Last Update Submit

August 22, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes of binge eating and purging episodes from baseline

    Measured by Eating Disorder Examination Questionnaire (EDE-Q, item 13 and 15). Core pathological behaviors of BN patients.

    Baseline, week 12 (end of the treatment), week 16 and week 24

Secondary Outcomes (6)

  • Change of disordered eating from baseline

    Baseline, week 12 (end of the treatment), week 16 and week 24

  • Changes of eating disorder related cognitive and behavioral characteristics

    Baseline, week 12 (end of the treatment), week 16 and week 24

  • Change of impulse control ability

    Baseline, week 12 (end of the treatment), week 16 and week 24

  • Change of depression level

    Baseline, week 12 (end of the treatment), week 16 and week 24

  • Change of anxiety level

    Baseline, week 12 (end of the treatment), week 16 and week 24

  • +1 more secondary outcomes

Study Arms (2)

online G-DBT

EXPERIMENTAL

Participants receive the G-DBT via videoconference weekly.

Behavioral: Online Group Dialectical Behavioral Therapy

face-to-face G-DBT

ACTIVE COMPARATOR

Participants attend the traditional G-DBT weekly in Shanghai Mental Health Center.

Behavioral: Face-to-face Group Dialectical Behavioral Therapy

Interventions

Online G-DBT is an adapted version of G-DBT delivered via video-conference. The specific design of G-DBT is the same as traditional face-to-face G-DBT. It also consists of 12 sessions, which is conducted weekly and lasts for 120 minutes. There are two therapists in charge of the therapy.

Also known as: Online G-DBT
online G-DBT

The G-DBT consists of 12 sessions, each lasting 120 minutes, and is held once a week. Two DBT therapists lead the patients to learn mindfulness skills, emotion regulation skills, pain tolerance skills, and interpersonal effectiveness skills. The aim is to help the patients reduce binge eating and harmful behaviors by regulating their emotions. Each sessions is conducted in a face-to-face way, in the psychological therapy room of the outpatient clinic in Shanghai Mental Health Center.

Also known as: Face-to-face G-DBT
face-to-face G-DBT

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Female, 18-35 years old, right-handed;
  • Education level is junior high school or above;
  • Meet the Diagnostic criteria of Bulimia Nervosa in DSM-5 (The diagnostic and statistical manual of mental disorders,DSM), body mass index (BMI)≥18.5 kg/m2;
  • Did not receive systematic nutritional therapy, psychiatric drug therapy or any form of psychological therapy within 1 month before enrollment;
  • Able to understand the study and agree to participate.

You may not qualify if:

  • Those who meet other DSM-5 diagnoses besides BN, such as substance abuse/dependence, depression, bipolar disorder, anxiety disorder, obsessive-compulsive disorder, etc. And those with high risk of suicide, strong disruptive impulse or antisocial behavior.
  • Patients with serious primary or secondary physical disease, cognitive impairment, so that they can not complete the required assessment.
  • Have received systematic nutritional therapy, individual and group psychotherapy previously.
  • Have taken neuroblockers, antidepressants, lithium salts, stimulants, antiepileptic drugs and other psychotropic drugs within the past 1 month.
  • For other reasons that researchers consider it inappropriate to participate in this clinical trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Mental Health Center

Shanghai, 200030, China

Location

MeSH Terms

Conditions

Bulimia Nervosa

Condition Hierarchy (Ancestors)

Feeding and Eating DisordersMental Disorders

Study Officials

  • Jue Chen, PhD

    Shanghai Mental Health Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Physician, Department Director

Study Record Dates

First Submitted

August 11, 2022

First Posted

August 17, 2026

Study Start

December 1, 2020

Primary Completion

November 30, 2022

Study Completion

November 30, 2023

Last Updated

August 25, 2026

Record last verified: 2026-08

Locations